Introduction. Women undergoing fertility treatment experience high levels of stress. However, it remains uncertain if and how stress influences in vitro fertilization (IVF) cycle outcome. This study aimed to investigate whether selfreported perceived and infertility-related stress and cortisol levels were associated with IVF cycle outcomes. Material and methods. A prospective cohort of 485 women receiving fertility treatment was recruited from September 2011 to December 2013 and followed until December 2014. Data were collected by online questionnaire prior to IVF start and from clinical charts. Salivary cortisol levels were measured. Associations between stress and cycle outcomes (clinical pregnancy and indicators of oocyte and embryo quality) were measured by logistic or linear regression, adjusted for age, body mass index, education, smoking, alcohol and caffeine consumption, shiftwork and night work. Results. Ultrasound verified pregnancy rate was 26.6% overall per cycle started and 32.9% per embryo transfer. Stress measures were not associated with clinical pregnancy: when compared with the lowest categories, the adjusted odds ratio (OR) and 95% confidence interval (CI) for the highest categories of the perceived stress score was 1.04 (95% CI 0.58-1.87), infertilityrelated stress score was OR = 1.18 (95% CI 0.56-2.47), morning and evening cortisol was OR = 1.18 (95% CI 0.60-2.29) and OR = 0.66 (95% CI 0.34-1.30), respectively. Conclusions. Perceived stress, infertility-related stress, and cortisol levels were not associated with IVF cycle outcomes. These findings are potentially reassuring to women undergoing fertility treatment with concerns about the influence of stress on their treatment outcome.
Introduction
The World Health Organization recognizes that both women and men suffer considerable psychological distress when experiencing reproductive health issues, including low self-esteem, isolation, loss of control, sexual inadequacy, and depression (1) . Infertility is defined as the inability to conceive after 1 year of unprotected intercourse. It is estimated that up to 28% of couples attempting to conceive will experience infertility (2) , and approximately half of infertile couples will seek fertility treatment (3) .
A multitude of studies have been published reporting higher stress levels and higher prevalence of symptoms of depression and anxiety among women receiving fertility treatment compared with the general population (4, 5) . The psychological impact of infertility has been suggested to be similar to other chronic medical conditions such as cancer, cardiac rehabilitation, and hypertension (6) . One study has reported that women with infertility to a large extent believed that stress had a role in their inability to conceive (7) , and patients undergoing fertility treatment are very often concerned that stress may decrease the likelihood of becoming pregnant.
It remains uncertain if and how psychological stress clinically affects the outcome of in vitro fertilization (IVF) treatments. Results from two meta-analyses including over 30 studies report conflicting conclusions (4, 5) . Notably, infertility-related stress has been reported to have direct and indirect effects on treatment outcome by at least one study (8) . Further, psychosocial interventions for couples in fertility treatment have been shown to be effective in both reducing psychological distress and improving clinical pregnancy rates (9) .
Similarly, efforts to measure the effect of physiological stress on IVF treatments have varied. A recent systematic review by Massey et al. in 2014 demonstrated that both high and low cortisol levels have been associated with increased likelihood of pregnancy in women undergoing IVF (10) . However, for the majority of included studies, the quality was rated as poor.
The aims of this prospective cohort study were to investigate the associations between perceived stress and physiological stress (i.e. cortisol levels) with IVF outcomes, including pregnancy rate as well as indicators of oocyte and embryo quality.
Material and methods
The UppStART study
The Uppsala-Stockholm Assisted Reproductive Techniques (UppStART) study is a prospective cohort study of couples undergoing IVF or intracytoplasmic sperm injection (ICSI) treatment in central Sweden. Recruitment took place from September 2011 to December 2013 at four clinics (three private and one public) in the greater Stockholm and Uppsala municipalities which provide healthcare for approximately 3 million people. All IVF cycles of participants were followed until December 2014. Understanding of the Swedish language was a requirement for participation. Couples undergoing treatment with donor sperm or donor eggs and couples undergoing preimplantation genetic diagnostic treatments were excluded. Only the first IVF cycle initiated after the baseline questionnaire response was included in this study.
Study population
In total, 485 of the UppStART participants were included in this study (Figure 1 ). Demographic and lifestyle data of study participants were obtained from the baseline questionnaire. A baseline questionnaire collected data on health and lifestyle and blood and saliva samples were collected. Clinical data extracted from the medical records included date of cycle start date (defined as the start date of downregulation in a gonadotropin-releasing hormone (GnRH) agonist treatment or follicle-stimulating hormone (FSH) stimulation in an antagonist treatment), oocyte and embryo parameters, and IVF cycle outcomes.
Exposure: stress measures
The 10-item version of the Perceived Stress Scale (PSS) (11) , translated into Swedish, was used to assess the degree to which the participants perceived their lives as unpredictable, uncontrollable, and overloaded in the previous three months on a four-point scale (never, rarely, often, very often). The final score was computed by summing the score of all 10 items. In the case of missing data, the item value was replaced by the mean of all nonmissing items multiplied by the number of items answered in the scale. Where two or more items were missing, the final score was set to missing.
Infertility-specific stress was assessed with the Copenhagen Multi-Center Psychosocial Infertility research program Fertility Problem Stress Scales (COMPI-FPSS) (12) , developed in Denmark and found to be a valid and reliable measure for Swedish populations as well (13) . The COMPI-FPSS assessed the stress associated with infertility within three domains (marital, social, personal) in the life of the participant using nine questions. The final "total fertility stress" score was calculated by summing the three domain scores and had a value ranging from 0 to 3.
To measure physiological stress, participants were provided with two pre-labeled Salivette â (Sarstedt, UK) kits, a pre-paid envelope for the return of samples to the Karolinska Biobank, and saliva collection instructions.
Samples were to be collected at home at 7:00 h (upon awakening and before breakfast and brushing of teeth) and at 21:00 h the same day, with no eating, drinking, gum chewing, snuff use or smoking in the 30 min prior to collection. Saliva samples were stored at À80°C until analysis. Cortisol levels (nmol/L) were measured by radioimmunoassay (RIA; Orion Diagnostic, Finland) by the Karolinska University Laboratory. Cortisol levels from samples taken 65 days before and up to two weeks after (n = 44) cycle start were included in the main analysis.
Outcome: IVF outcomes
The treatment outcomes were whether the woman underwent oocyte aspiration (yes/no), embryo transfer (yes/ no), and whether the embryo transfer resulted in an ultrasound verified clinical pregnancy (yes/no). Treatment-specific outcomes included: oocyte maturity rate (defined as the ratio of aspirated oocytes used for the IVF/ICSI procedure to the total number of aspirated oocytes), the embryo utilization rate (defined as the ratio of the number of embryos that were either transferred or frozen to the total number of embryos created), and an average integrated morphology cleavage (IMC) embryo score generated by the clinic software, calculated on a 10-point scale using specific Day 2 embryo parameters (blastomere number, presence of multinucleation, and the size variation of the blastomeres) (14) . An average IMC embryo score was available only for a subset of women (n = 147) receiving treatment at one of the four clinics.
Covariates
Data from the baseline questionnaire and the clinical data were combined in order to have as complete information as possible for age, smoking status, reason for infertility, length of infertility, diagnoses of polycystic ovary syndrome, endometriosis, depression, and use of antidepressants. Data on body mass index (BMI) were extracted from clinical records; when missing, data were calculated from the self-reported height and weight. Participants were asked to report specific sources of caffeine (coffee, tea, cola, energy drinks) and the volumes ingested on a daily or weekly basis in the previous three months, and total daily intake of caffeine was calculated. Physical activity level (PAL) was calculated using the validated "PAL" method (15) , and then divided into low, moderate, and high levels of physical activity.
Statistical analysis
Pearson's coefficients were calculated between the four measures of stress (PSS, COMPI-FPSS, morning and evening cortisol) and presented in a matrix to assess the linear relation of the measures.
To assess the association between stress and IVF treatment outcomes, logistic regression analysis was used to estimate odds ratios (OR) with 95% confidence intervals (CI) for not achieving an oocyte aspiration, embryo transfer or pregnancy per embryo transfer. The lowest stress level was chosen as the reference category for both measures of stress evaluated by questionnaire (PSS and COMPI-FPSS). The middle tertile of mean cortisol was chosen as the reference category because both high and low levels of cortisol have been associated with stress and various pathologies.
Factors previously reported to be associated with IVF outcome and cortisol levels were included as covariates in the logistic regression models in two steps. Model 1 adjusted for age as a continuous variable and Model 2 adjusted for age, BMI in categories, high vs. low education, current smoking, alcohol consumption, daily caffeine consumption in categories, current shiftwork, and current night work.
Linear regression analysis was used to estimate the association between the measures of stress, the oocyte maturity rate, the embryo utilization rate, and average IMC embryo score. Adjusted analyses were conducted using similar covariate adjustment as described above.
All analyses were conducted in STATA version 14 (StataCorp LLC, College Station, TX, USA).
Ethical approval
The study was granted ethical approval by the Stockholm Regional Ethics Committee (Dnr 2011/230-31/1, 2011/ 1427-32, 2012/131-32, 2012/792-32, 2013/1700-32). All participants provided informed consent before participating in the study and were notified that they had the option to withdraw at any time without consequences to their medical care.
Results

Descriptive
Mean age of the participants was 33.8 years. The majority of women had a BMI within the normal category, were non-smokers, had drunk alcohol in the three months prior to cycle start, were educated at university level, were moderately physically active, and had low to moderate daily caffeine intake ( Table 1) .
After IVF cycle start, 10.3% of women did not progress to an oocyte aspiration procedure. These women presented with higher BMI, were more likely to be smokers and perform shiftwork, and to have female factor infertility. Reasons for not undergoing aspiration were not explicitly stated in the clinical data; however, it was noted in some cases that ovarian stimulation had been interrupted, and for those who underwent a pre-aspiration ultrasound, fewer follicles were reported compared with those women who underwent aspiration.
Of the women who did have an oocyte aspiration, 90% (n = 391) underwent subsequent ET and had significantly more oocytes retrieved at aspiration (mean AE SD = 9.6 AE 4.3 vs. 6.3 AE 5.0; p < 0.001) and a significantly higher maturity rate (mean AE SD = 0.93 AE 0.14 vs. 0.80 AE 0.36; p < 0.001) compared with those who did not have an ET. Consequently, significantly more embryos were created (mean AE SD = 5.6 AE 3.1 vs. 2.4 AE 4.4; p < 0.001) and the embryo utilization rate was higher (mean AE SD = 0.60 AE 0.27 vs. 0.10 AE 0.24, p < 0.001). Among the subset of women with average IMC embryo score data, those who had an ET had a higher mean average score than those who did not have an ET (mean AE SD = 7.5 AE 1.5 vs. 4.9 AE 3.9, p = 0.009).
Pregnancy rate per embryo transfer was 32.9% (n = 129) and 26.6% per IVF treatment started. Single embryo transfers accounted for 89% of all embryo transfers for which the pregnancy rate was 33.5%. Pregnancy rate for double embryo transfers was 29%. There were no differences between women who had a clinical pregnancy following ET and women who did not become pregnant with respect to the number of aspirated oocytes, the oocyte maturity rate, embryo utilization rate, and average IMC embryo score (data not shown). There was an association between increasing age and lower rates of clinical pregnancy (Table 1) .
Stress
Of the four measures of stress, increasing scores from the two questionnaire-based methods (PSS and COMPI-FPSS) were significantly correlated to each other, but not to cortisol levels ( Table 2) . Reporting a diagnosis of depression or the use of antidepressants was associated with higher perceived stress scores, whereas being of an older age or having a previous child was associated with a lower score. Increasing levels of physical activity were associated higher total infertility stress scores (Table 3) .
Overall, none of the measures of stress was associated with whether a woman had an oocyte aspiration, embryo transfer or pregnancy per embryo transfer (Table 4) . Stress measures were not associated with oocyte maturity rate or the embryo utilization rate. Increasing levels of evening cortisol were significantly associated with decreasing mean average IMC embryo score (Table 5) .
Sensitivity analysis
Morning cortisol samples were restricted to those taken between the hours of 07:00 and 09:00 h (n = 266, 82%). Results from the crude and adjusted analyses did not differ significantly from the main analysis. Analyses including only saliva samples collected in the 10 days prior to cycle start (morning: n = 74, evening: n = 76) produced similar results to the main analysis (data not shown).
Saliva samples for cortisol analysis were missing for 164 of the 485 women (34%). Women with missing samples had significantly lower rates of having an oocyte aspiration (81 vs. 94%, p < 0.001) but did not have higher levels of stress measured from the baseline questionnaire (PSS and COMPI-FPSS).
Discussion
In a prospective cohort of 485 women living in the greater Stockholm region, we found no association between self-reported stress or cortisol measures and IVF outcomes, including whether the cycle progressed to oocyte aspiration, embryo transfer or resulted in pregnancy. Additionally, there were no significant associations between stress and indicators of oocyte and embryo quality except between evening cortisol and average IMC embryo score.
Only two studies have reported a link between serum cortisol and clinical pregnancy following an IVF cycle, where higher levels of cortisol were associated with decreased pregnancy rate (16, 17) . Only one study has measured cortisol from saliva: Nouri et al. (2011) defined high stress by either low levels of morning salivary cortisol or high scores on the Fertility Problem Inventory (FPI) questionnaire and found that stress did not impact the number of oocytes collected at aspiration, clinical pregnancy rate or live birth rate (18) . Most recently, Massey et al. (2016) measured cortisol from both saliva and hair in a sample of 158 women; hair cortisol significantly predicted clinical pregnancy, but salivary cortisol did not (19) .
The Perceived Stress Scale measures the degree to which situations in one's life are thought of as stressful (11) . The PSS has previously been applied to an infertility-specific study population, where lower perceived stress at the time of embryo transfer, but not prior to cycle start, was found to be associated with a higher pregnancy rate (20) . The COMPI Fertility Problems Stress scale (COMPI-FPSS) has been found to be a reliable and valid measure of assessing the psychosocial impact of infertility and has been used extensively in infertile populations (21) . Higher overall fertility problem stress was associated with lower rates of pregnancy and live birth in the Danish cohort of over 800 women undergoing IVF in which this COMPI scale was developed (8), a finding that we did not replicate in our study.
It has been reported that in healthy women with no known reproductive disorders, high vs. low daily stress measured by the 14-question version of the PSS was associated to menstrual cycle function and hormone levels; for each unit of increase in daily stress level, women had 70% higher odds of experiencing anovulation (22). Although anovulation may be a mechanism through which stress leads to conception difficulties, fertility treatments attempt to overcome the issue of anovulation via ovarian stimulation and ovulation induction, and may therefore bypass the influence of stress, which could provide a possible explanation for our findings. Characteristics of the women in this study are typical of couples experiencing infertility and undergoing IVF procedures in Sweden -of older reproductive age and higher education, with generally healthy lifestyles including normal BMI, low rates of smoking, low to moderate caffeine intake and physical activity levels, and a representative distribution of female-factor, male-factor and unknown/mixed causes of infertility. Fewer women than expected -only <3% -reported having a diagnosis of depression or taking an antidepressant. We previously reported in a register-based study of all women undergoing an IVF cycle in Sweden between 2007 and 2013 that 4.4% of women had either a diagnosis of depression or dispensation of antidepressant medication prior to the start of their cycle (23) . We speculate that women who are highly stressed and/or depressed are less likely to take on the additional burden of participating in a research study while undergoing IVF treatment.
This study contains one of the largest samples of women in which the association between stress and IVF outcome has been addressed. It is unique in that it measures both the physiological and psychological aspects of stress prior to IVF cycle start and outcomes were not limited to only pregnancy rate as in many previous studies. The UppStART study is also rich in data on lifestyle covariates that could be adjusted for. There is a large degree of homogeneity in this sample of women, with low exposure to factors known to affect fertility and IVF outcome (for example, high BMI, smoking), and covariates known to affect the cortisol levels (for example, smoking, caffeine consumption). Therefore, confounding is likely of minor importance for the associations analyzed. Indeed, the two adjusted models differ very little from each other and from the crude analysis results. As with known covariates, we speculate that any unmeasured confounders are likely to be relatively homogeneous among the study sample.
The main limitation in this study is that stress was only measured at one time point. Preferably, stress should have been measured at baseline and at specific time points throughout the IVF treatment cycle. Additionally, salivary cortisol is ideally used as an acute measure of stress and is a hormone with large intra-and interindividual variation in response to stressful situations and influenced by lifestyle factors, exposure to chronic stress, and genetics (24) . New techniques of extracting cortisol from hair have emerged since this study was designed Ref.
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Ref. Oocyte maturity rate is the ratio of the number of oocytes used for the IVF or ICSI procedure, to the total number of oocytes aspirated. 2 Embryo utilization rate is the ratio of the number of embryos transferred or frozen, to the total number of embryos created. 3 Average IMC embryo score data were available only for a subset of 147 women. and implemented, and may provide a better way of measuring the influence of longer term cortisol levels and chronic stress on IVF treatment outcome. Lastly, although the study sample is larger than most, null findings may be attributable to low power, as we are not likely to be able to detect small increases in risk. Overall, we found that stress measured prior to IVF cycle start was not associated with cycle outcome, oocyte maturity or embryo quality. Undeniably, women undergoing fertility treatment experience higher levels of stress. Psychosocial care is recommended for couples undergoing fertility treatment (25) and has been shown to be effective in reducing plasma cortisol levels (26) and psychological distress, and, paradoxically, improving clinical pregnancy rates (9) . However, psychosocial care may not be available or effective for all patients, and the value of the knowledge gained from elucidating the influence of stress on fertility is the motivation for continued research in this field. The findings from this study and many other studies reporting a lack of an association between stress and IVF outcomes, are potentially reassuring to women undergoing fertility treatment and their clinicians who may have concerns about the influence of stress levels on the success of their IVF treatment.
